Literature DB >> 23867149

The prototypical histamine H3 receptor inverse agonist thioperamide improves multiple aspects of memory processing in an inhibitory avoidance task.

Yana Charlier1, Christian Brabant, Maria Elisa Serrano, Yves Lamberty, Ezio Tirelli.   

Abstract

Numerous studies have found that histamine plays a major role in memory and that the histamine H3 receptor (H3R) inverse agonist thioperamide improves cognitive performance in various animal models. However, little is known about the stages of memory that are specifically affected by thioperamide. The purpose of the present study was to investigate the effects of thioperamide on acquisition, consolidation and retrieval processes in a one-trial inhibitory avoidance task in female C57BL/6J mice. In addition, potential state-dependency effects were studied by injecting thioperamide before the training and the test sessions in order to induce similar physiological states during acquisition and retrieval. Our results indicate that post-training systemic administration of thioperamide facilitated consolidation. Moreover, the administration of thioperamide before the training session had no effect on latency to enter the black compartment during training but enhanced memory during the retention test. The administration of thioperamide before the retention test also increased performance, which indicates that this compound ameliorates memory retrieval. Finally, when animals received thioperamide before the training session and before the retention test, the cognitive enhancing effects of thioperamide were not significantly changed. Together, our results show that thioperamide improves cognitive performance in an inhibitory avoidance task through actions on different memory stages. Furthermore, inducing a similar physiological state with thioperamide during acquisition and retrieval do not significantly affect cognitive enhancement. Our results suggest that the blockade of H3R can be helpful for the treatment of neuropsychiatric conditions characterized by deficits affecting several stages of memory processing.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Histamine; Inhibitory avoidance; Memory; Mice; State-dependent learning; Thioperamide

Mesh:

Substances:

Year:  2013        PMID: 23867149     DOI: 10.1016/j.bbr.2013.07.016

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  7 in total

1.  Low-dose thioperamide injected into the cerebellar vermis of mice immediately after exposure to the elevated plus-maze impairs their avoidance behavior on re-exposure to the apparatus.

Authors:  J Costa; K R Serafim; A C L Gianlorenço; R Mattioli
Journal:  Braz J Med Biol Res       Date:  2013-11-06       Impact factor: 2.590

Review 2.  Perspectives for New and More Efficient Multifunctional Ligands for Alzheimer's Disease Therapy.

Authors:  Agnieszka Zagórska; Anna Jaromin
Journal:  Molecules       Date:  2020-07-23       Impact factor: 4.411

3.  Histamine H3 receptor antagonist E177 attenuates amnesia induced by dizocilpine without modulation of anxiety-like behaviors in rats.

Authors:  Alaa Alachkar; Nadia Khan; Dorota Łażewska; Katarzyna Kieć-Kononowicz; Bassem Sadek
Journal:  Neuropsychiatr Dis Treat       Date:  2019-02-20       Impact factor: 2.570

4.  Selective H3 Antagonist (ABT-239) Differentially Modifies Cognitive Function Under the Impact of Restraint Stress.

Authors:  Emil Trofimiuk; Przemysław Wielgat; Halina Car
Journal:  Front Syst Neurosci       Date:  2021-02-02

5.  The Histamine H3 Receptor Antagonist DL77 Ameliorates MK801-Induced Memory Deficits in Rats.

Authors:  Nermin Eissa; Nadia Khan; Shreesh K Ojha; Dorota Łazewska; Katarzyna Kieć-Kononowicz; Bassem Sadek
Journal:  Front Neurosci       Date:  2018-02-12       Impact factor: 4.677

6.  The Histamine H3 Receptor Antagonist E159 Reverses Memory Deficits Induced by Dizocilpine in Passive Avoidance and Novel Object Recognition Paradigm in Rats.

Authors:  Alaa Alachkar; Dorota Łażewska; Katarzyna Kieć-Kononowicz; Bassem Sadek
Journal:  Front Pharmacol       Date:  2017-10-12       Impact factor: 5.810

7.  Modulation of dopamine D1 receptors via histamine H3 receptors is a novel therapeutic target for Huntington's disease.

Authors:  David Moreno-Delgado; Mar Puigdellívol; Silvia Ginés; Peter J McCormick; Estefanía Moreno; Mar Rodríguez-Ruiz; Joaquín Botta; Paola Gasperini; Anna Chiarlone; Lesley A Howell; Marco Scarselli; Vicent Casadó; Antoni Cortés; Sergi Ferré; Manuel Guzmán; Carmen Lluís; Jordi Alberch; Enric I Canela
Journal:  Elife       Date:  2020-06-09       Impact factor: 8.140

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.